Efficacy and tolerability of perampanel in patients with seizures in real-world clinical practice: A systematic review and meta-analysis

Efficacy and tolerability of perampanel in patients with seizures in real-world clinical practice: A systematic review and meta-analysis

Objectives: The aim of this study was to systematically review the efficacy and tolerability of perampanel (PER) when used as add-on treatment or monotherapy in patients with epilepsy aged 12 years and older in routine clinical practice.Methods: Electronic and clinical trials databases were searched...

Full description

Bibliographic Details
Main Authors:	Liyan Hou, Jingjing Yang, Xuan Zhang, Na Li, Sheng Li, Lei Zhang, Jie Zhao, Qingshan Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Pharmacology
Subjects:	seizures meta-analysis real-world study perampanel systemic review
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1139514/full

Similar Items

Effectiveness of perampanel as the only add‐on: Retrospective, multicenter, observational real‐life study on epilepsy patients
by: Sara Gasparini, et al.
Published: (2022-12-01)

Efficacy and Tolerability of Perampanel as Adjunctive Therapy in Chinese Patients With Focal-Onset Seizures: An Observational, Prospective Study
by: Ranran Zhang, et al.
Published: (2021-08-01)

Spotlight on perampanel in the management of seizures: design, development and an update on place in therapy
by: Faulkner MA
Published: (2017-10-01)

Efficacy and safety of perampanel as early add-on therapy in Chinese patients with focal-onset seizures: a multicenter, open-label, single-arm study
by: Lehong Gao, et al.
Published: (2023-08-01)

Efficacy and tolerability of perampanel: a Chinese real-world observational study in epilepsy
by: Ya Zeng, et al.
Published: (2024-01-01)

Perampanel: New drug for treatment of refractory partial onset seizures
by: Santosh Kumar Singh, et al.
Published: (2014-01-01)

Optimal Use of Perampanel in Asian Patients with Epilepsy: Expert Opinion
by: Chinvarun Y, et al.
Published: (2021-07-01)

Perampanel as add-on therapy in epilepsies with known etiology: A single center experience with long-term follow-up
by: Annacarmen Nilo, et al.
Published: (2021-01-01)

Efficacy and Safety of Perampanel in Children with Drug-Resistant Focal-Onset Seizures: A Retrospective Review
by: Ahmed Elmardenly, et al.
Published: (2023-06-01)

The efficacy and safety of adjunctive perampanel for the treatment of refractory focal‐onset seizures in patients with epilepsy: A meta‐analysis
by: Yiming Li, et al.
Published: (2022-06-01)

Perampanel in adjunctive therapy of patients with brain tumor-related epilepsy: real-world data
by: G. G. Samsonova, et al.
Published: (2023-01-01)

Efficacy and safety of perampanel monotherapy in Chinese patients with focal‐onset seizures: A single‐center, prospective, real‐world observational study
by: Haiyan Ma, et al.
Published: (2023-12-01)

An Evidence-Based Review On The Use Of Perampanel For The Treatment Of Focal-Onset Seizures In Pediatric Patients
by: Dozières-Puyravel B, et al.
Published: (2019-09-01)

Optimal Use of Perampanel in Elderly Asian Patients with Epilepsy: Expert Opinion
by: Huang CW, et al.
Published: (2022-08-01)

Frontal Hypoperfusion and the Effectiveness of Perampanel in Long-Lived Patient with Lafora Disease
by: Koji Obara, et al.
Published: (2021-03-01)

Value of Perampanel as Adjunctive Treatment for Partial-Onset Seizures in Epilepsy: Cost-Effectiveness and Budget Impact Analysis
by: Donger Zhang, et al.
Published: (2021-07-01)

Long‐term open‐label perampanel: Generalized tonic–clonic seizures in idiopathic generalized epilepsy
by: Jacqueline A. French, et al.
Published: (2022-09-01)

Long‐term efficacy and safety of adjunctive perampanel in patients from the Asia‐Pacific region with refractory focal‐onset seizures in Study 335 open‐label extension
by: Takuji Nishida, et al.
Published: (2024-04-01)

Initial therapeutic target attainment of perampanel in pediatric patients with epilepsy
by: Lingyan Yu, et al.
Published: (2023-11-01)

Efficacy and safety of perampanel monotherapy in patients with focal‐onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: The open‐label Study 342 (FREEDOM Study)
by: Takamichi Yamamoto, et al.
Published: (2020-06-01)

Successful use of perampanel in GABRA1-related myoclonic epilepsy with photosensitivity
by: Sara Olivotto, et al.
Published: (2022-01-01)

Intravenous perampanel as an alternative to the oral formulations in Japanese patients with epilepsy
by: Ryosuke Hanaya, et al.
Published: (2023-12-01)

Efficacy and safety of adjunctive perampanel in patients with focal seizures or generalized tonic‐clonic seizures: Post hoc analysis of Phase II and Phase III double‐blind and open‐label extension studies in India
by: Man M. Mehndiratta, et al.
Published: (2021-03-01)

Perampanel’s forgiveness factor in a variable medication adherence paradigm in a rat model of chronic epilepsy
by: Michelle Guignet, et al.
Published: (2023-09-01)

Perampanel during pregnancy: Description of four cases
by: A.M. Alicino, et al.
Published: (2021-01-01)

Case report: Off-label use of low-dose perampanel in a 25-month-old girl with a pathogenic SYNGAP1 variant
by: Siddharth Gupta, et al.
Published: (2023-08-01)

Seizure control and improvement of neurological dysfunction in Lafora disease with perampanel
by: Maya Dirani, et al.
Published: (2014-01-01)

WRAPPER study: Real‐world effectiveness and tolerability of adjunctive perampanel for people with drug–resistant epilepsy in Hong Kong
by: Charlie C. H. Chan, et al.
Published: (2024-02-01)

Effectiveness and tolerability of perampanel monotherapy in children with newly diagnosed focal epilepsy
by: Fen Zhao, et al.
Published: (2023-05-01)

Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy
by: Jia-Qin Yi, et al.
Published: (2023-08-01)

Perampanel in cases of refractory temporal lobe epilepsy – A report of two post-operative and two eligible for temporal lobectomy
by: Anoop Kohli, et al.
Published: (2021-06-01)

Corrigendum: Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy
by: Jia-Qin Yi, et al.
Published: (2023-09-01)

Clinical Efficacy and Safety of Lacosamide as an Adjunctive Treatment in Adults With Refractory Epilepsy
by: Liyan Hou, et al.
Published: (2021-12-01)

Efficacy and safety of Perampanel in the treatment of post stroke epilepsy: A multicenter, real-world study
by: Cuihua Yan, et al.
Published: (2024-03-01)

Long-term treatment with Perampanel of Chinese patients with focal-onset seizures, especially in sleep-related epilepsy: a prospective real-world observational study
by: Ye Xu, et al.
Published: (2024-02-01)

Preliminary Asian experience of using perampanel in clinical practice
by: Hsing-I Chiang, et al.
Published: (2017-12-01)

Remarkable improvement of primary orthostatic tremor using perampanel
by: Marcus Grobe-Einsler, et al.
Published: (2020-01-01)

BUDGET IMPACT ANALYSIS OF PERAMPANEL FOR ADJUNCTIVE TREATMENT IN EPILEPSY PATIENTS 12 YEARS OF AGE AND OLDER FOR PARTIAL ONSET SEIZURES WITH OR WITHOUT SECONDARY GENERALIZATION AND PRIMARY GENERALIZED TONIC-CLONIC SEIZURES IN THE RUSSIAN FEDERATION
by: V. R. Mkrtchyan, et al.
Published: (2016-09-01)

Efficacy and Tolerability of Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review
by: Jessica Rossi, et al.
Published: (2023-02-01)

Efficacy and adverse reactions of perampanel in the treatment of epilepsy in children
by: Dan Li, et al.
Published: (2022-07-01)